Literature DB >> 27052224

[Antihypertensive therapy in diabetes mellitus: Guidelines of the Austrian Diabetes Association 2016].

Guntram Schernthaner1, Heinz Drexel2, Alexander Rosenkranz3, Gerit-Holger Schernthaner4, Bruno Watschinger5.   

Abstract

Blood pressure lowering is one of the most important interventions for reducing the vascular complications and mortality in patients with diabetes mellitus. Recent studies indicate that the optimal blood pressure level might be in the range between 130-140 mmHg systolic and 80‒90 mmHg diastolic. Lower blood pressure levels (e.g. 120/80 mmHg) can further reduce the risk for stroke and diabetic nephropathy, but are associated with increased cardiovascular mortality. In particular, very low blood pressure levels (< 120 mmHg) should be avoided in patients with coronary heart disease or peripheral arterial disease. Most patients with diabetes mellitus need antihypertensive combination therapies, whereby ACE-inhibitors or Angiotensin-II receptor antagonists should be first line drugs.

Entities:  

Keywords:  Antihypertensive therapy; Blood pressure lowering; Diabetes mellitus; Diabetic nephropathy; Myocardial infarction; Peripheral arterial disease; Stroke

Mesh:

Substances:

Year:  2016        PMID: 27052224     DOI: 10.1007/s00508-015-0924-2

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  32 in total

Review 1.  Standards of medical care in diabetes--2012.

Authors: 
Journal:  Diabetes Care       Date:  2012-01       Impact factor: 19.112

2.  Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention.

Authors:  Clive Rosendorff; Henry R Black; Christopher P Cannon; Bernard J Gersh; Joel Gore; Joseph L Izzo; Norman M Kaplan; Christopher M O'Connor; Patrick T O'Gara; Suzanne Oparil
Journal:  Circulation       Date:  2007-05-14       Impact factor: 29.690

3.  Blood pressure control in diabetes mellitus: is lower always better, and how low should it go?

Authors:  Prakash C Deedwania
Journal:  Circulation       Date:  2011-06-21       Impact factor: 29.690

4.  Outcomes Among hypertensive patients with concomitant peripheral and coronary artery disease: findings from the INternational VErapamil-SR/Trandolapril STudy.

Authors:  Anthony A Bavry; R David Anderson; Yan Gong; Scott J Denardo; Rhonda M Cooper-Dehoff; Eileen M Handberg; Carl J Pepine
Journal:  Hypertension       Date:  2009-12-07       Impact factor: 10.190

5.  Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial).

Authors:  Josep Redon; Giuseppe Mancia; Peter Sleight; Helmut Schumacher; Peggy Gao; Janice Pogue; Robert Fagard; Paolo Verdecchia; Michael Weber; Michael Böhm; Bryan Williams; Khalid Yusoff; Koon Teo; Salim Yusuf
Journal:  J Am Coll Cardiol       Date:  2012-01-03       Impact factor: 24.094

6.  Effects of intensive blood-pressure control in type 2 diabetes mellitus.

Authors:  William C Cushman; Gregory W Evans; Robert P Byington; David C Goff; Richard H Grimm; Jeffrey A Cutler; Denise G Simons-Morton; Jan N Basile; Marshall A Corson; Jeffrey L Probstfield; Lois Katz; Kevin A Peterson; William T Friedewald; John B Buse; J Thomas Bigger; Hertzel C Gerstein; Faramarz Ismail-Beigi
Journal:  N Engl J Med       Date:  2010-03-14       Impact factor: 91.245

7.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

Review 8.  Diabetes and hypertension: the bad companions.

Authors:  Ele Ferrannini; William C Cushman
Journal:  Lancet       Date:  2012-08-11       Impact factor: 79.321

9.  Impact of peripheral arterial disease in patients with diabetes--results from PROactive (PROactive 11).

Authors:  J A Dormandy; D J Betteridge; G Schernthaner; V Pirags; L Norgren
Journal:  Atherosclerosis       Date:  2008-03-18       Impact factor: 5.162

10.  Long-term and recent progress in blood pressure levels among U.S. adults with diagnosed diabetes, 1988-2008.

Authors:  Jing Wang; Linda S Geiss; Yiling J Cheng; Giuseppina Imperatore; Sharon H Saydah; Cherie James; Edward W Gregg
Journal:  Diabetes Care       Date:  2011-05-20       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.